VYNE Therapeutics Inc (VYNE)
2.79
+0.09
(+3.33%)
USD |
NASDAQ |
May 17, 16:00
2.79
0.00 (0.00%)
Pre-Market: 20:00
VYNE Therapeutics 1 Year Total Returns (Daily): -61.42% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -61.42% |
| May 16, 2024 | -61.70% |
| May 15, 2024 | -64.06% |
| May 14, 2024 | -60.03% |
| May 13, 2024 | -60.86% |
| May 10, 2024 | -55.35% |
| May 09, 2024 | -65.98% |
| May 08, 2024 | -68.59% |
| May 07, 2024 | -63.69% |
| May 06, 2024 | -65.95% |
| May 03, 2024 | -57.95% |
| May 02, 2024 | -59.02% |
| May 01, 2024 | -58.11% |
| April 30, 2024 | -52.09% |
| April 29, 2024 | -50.00% |
| April 26, 2024 | -55.36% |
| April 25, 2024 | -44.74% |
| April 24, 2024 | -40.78% |
| April 23, 2024 | -44.10% |
| April 22, 2024 | -43.37% |
| April 19, 2024 | -49.55% |
| April 18, 2024 | -26.52% |
| April 17, 2024 | -18.09% |
| April 16, 2024 | -11.03% |
| April 15, 2024 | -5.51% |
| Date | Value |
|---|---|
| April 12, 2024 | 1.09% |
| April 11, 2024 | 9.88% |
| April 10, 2024 | -0.74% |
| April 09, 2024 | 1.47% |
| April 08, 2024 | 0.74% |
| April 05, 2024 | 9.69% |
| April 04, 2024 | -0.65% |
| April 03, 2024 | 4.73% |
| April 02, 2024 | -1.95% |
| April 01, 2024 | 0.00% |
| March 28, 2024 | 16.73% |
| March 27, 2024 | 10.45% |
| March 26, 2024 | 9.27% |
| March 25, 2024 | -4.63% |
| March 22, 2024 | -4.35% |
| March 21, 2024 | -14.02% |
| March 20, 2024 | -14.51% |
| March 19, 2024 | -16.40% |
| March 18, 2024 | -23.20% |
| March 15, 2024 | -21.18% |
| March 14, 2024 | -14.52% |
| March 13, 2024 | -14.52% |
| March 12, 2024 | -19.54% |
| March 11, 2024 | -18.01% |
| March 08, 2024 | -26.63% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.40%
Minimum
Feb 09 2022
56.43%
Maximum
Apr 07 2021
-54.66%
Average
-59.95%
Median
Oct 06 2020
1 Year Total Returns (Daily) Benchmarks
| Viking Therapeutics Inc | 174.5% |
| AN2 Therapeutics Inc | -72.58% |
| NovaBay Pharmaceuticals Inc | -83.53% |
| Palatin Technologies Inc | -18.03% |
| iBio Inc | -89.71% |